Activity of oral agents against pediatric isolates of Streptococcus pneumoniae

被引：3

作者：

Black, J

Moland, ES

Chartrand, SA

Thomson, KS

机构：

[1] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Ctr Res Anti Infect & Biotechnol, Omaha, NE 68178 USA

[2] Creighton Univ, Sch Med, Dept Pediat Infect Dis, Omaha, NE 68178 USA

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2001年 / 39卷 / 03期

关键词：

D O I：

10.1016/S0732-8893(01)00209-7

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

An in vitro study of the activity of 10 oral agents against 153 pediatric isolates of Streptococcus pneumoniae identified moxifloxacin and levofloxacin as the most active agents regardless of penicillin or macrolide susceptibility. Moxifloxacin inhibited all strains at 0.25 mug/ml and was 8- to 16-fold more potent than levofloxacin. (C) 2001 Elsevier Science inc. All rights reserved.

引用

页码：195 / 197

页数：3

共 11 条

[1] Fluoroquinolones as treatment for patients with lower respiratory tract infections caused by Streptococcus pneumoniae [J].